Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRR29 antisense RNA 1 (PRR29-AS1) is a long noncoding RNA (lncRNA) gene located on human chromosome 17. It is transcribed from the opposite strand of the PRR29 protein-coding gene. PRR29-AS1 is categorized as an antisense RNA, a class of lncRNAs that may regulate the expression of neighboring or overlapping coding genes, although no direct functional roles, biological pathways, or disease associations have yet been described for this specific RNA[2][3][8][10]. There are no current reports of PRR29-AS1 being a therapeutic target, nor are there data on interacting drugs, mechanisms of action, biomarker utility, or safety considerations in a clinical context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRR29 antisense RNA 1 (PRR29-AS1).